Dr. David Lagrew Jr.

Expert Publications

• Ethnic differences in birth weight by gestational age: at least a partial explanation for the Hispanic epidemiologic paradox?
• Intrinsic racial differences in the risk of cesarean delivery are not explained
• Emergent (crash) cesarean delivery: indications and outcomes.
• Previous cesarean section and the risk of postpartum maternal complications and adverse neonatal outcomes in future pregnancies.
• Gestational age at cervical length measurement and preterm birth in twins.
• The relationship between previous treatment for cervical dysplasia and preterm delivery in twin gestations.
• Postpartum hemorrhage: state and national response.
• Cost comparison of robotic-assisted laparoscopic hysterectomy versus standard laparoscopic hysterectomy.
• Standardizing Maternity Care Data to Improve Coordination of Care.
• Evaluation of the anthracene-benzene chemical light meter for ecological research.
• Accuracy of Blood Loss Measurement during Cesarean Delivery.
• Fetal evaluation in early gestational ages.
• Unexplained fetal baseline bradycardia in congenital panhypopituitarism.
• Management of postdate pregnancy.
• Disseminated herpes simplex virus infection in pregnancy. Successful treatment with acyclovir.

Media Releases

Elevating Maternal Fetal Medicine at Hoag Women’s Health Institute

Newport Beach, California - As the Chief of Service of Maternal Fetal Medicine at Hoag Women’s Health Institute, Dr. David Lagrew Jr., brings decades of expertise and a passion for improving women’s health to his role. Specializing in perinatology, he is dedicated to providing personalized, integrated care to women at every stage of their health journey.

Founded on the principles of prevention, wellness, and treatment, the Hoag Women’s Health Institute is a beacon of excellence in women’s healthcare. Its multidisciplinary team of exceptional providers leverage leading-edge technology and facilities to ensure that women receive the highest quality care possible.

A native of Lexington, Kentucky, Dr. Lagrew Jr. earned his Medical Degree from the University of Kentucky College of Medicine in 1979. He completed his internship and residency in obstetrics and gynecology at University Hospital in Lexington before pursuing a fellowship in maternal-fetal medicine at the University of California, Irvine Medical Center.

With an illustrious career in the medical field, Dr. Lagrew Jr. has held key leadership positions at prestigious institutions, starting with his role as Medical Director of Women’s Hospital at Saddleback Memorial Medical Center from March 1988 to March 2010. Concurrently, he served as Medical Director at Long Beach Memorial Medical Center from January 1996 to March 2012. 

Following these roles, Dr. Lagrew Jr. became Chief Integration and Accountability Officer at MemorialCare Health System from March 2010 to April 2016, also holding the title of Chief Integration and Accountability Officer from 2011 to 2012. Subsequently, he served as Executive Medical Director of Women’s Services at Providence, St. Joseph Health from October 2016 to July 2022. Most recently, Dr. Lange has been a Board Member at Cern Corporation since May 2021.

Board certified in obstetrics and gynecology, maternal-fetal medicine, and clinical informatics, Dr. Lagrew Jr. is a distinguished member of professional organizations such as the American College of Obstetricians and Gynecologists, the Society for Maternal-Fetal Medicine, and the Pacific Coast Obstetrical and Gynecological Society.

Continuing to contribute to the advancement of medical knowledge, Dr. Lagrew Jr. is a prolific author of peer-reviewed publications and book chapters, solidifying his reputation as a thought leader in perinatology.

For women seeking compassionate, expert care in maternal-fetal medicine, Dr. David Lagrew Jr. and the Hoag Women’s Health Institute stand as beacons of hope and healing, dedicated to empowering women to lead their healthiest, happiest lives.

Recommended Articles

• What Is Estarylla?

  Estarylla is a combination hormone medication, which contains progestin (norgestimate) and estrogen (ethinyl estradiol). It is used to prevent pregnancy by inhibiting ovulation (release of an egg during a woman's menstrual period). It also prevents the sperm to reach the egg by making the vaginal...

• How Your Father’s Genes Can Affect Your Ovarian Cancer Risk

  It is well known that inherited mutations in BRCA1/BRCA2 genes increase the risk of breast and ovarian cancers, as well as other types of cancer. An altered mutation in the BRCA1 or BRCA2 gene can be inherited from an individual’s mother or father. ...

• How Do I Treat Uterine Fibroids?

  Uterine fibroids are noncancerous growths that develop from the fibrous and smooth muscle layers of the uterus. The size of these uterine leiomyomas vary in size and range from a small pea to that of a melon. It is a very common condition, and affects about 20 percent of women. Uterine fibroids are...

• Recovering from a Laparoscopy

  Patients who have undergone laparoscopic surgery tell of different stories. They have varying views and opinions. Some say it is a harrowing experience, while others consider laparoscopy a minor surgery. It really all depends on the individual, because every human being responds differently to...

• Does My Heavy Menstruation Mean I Have Fibroids?

  Heavy periods are very common, and for most cases, the real cause is unknown. However, fibroids and endometriosis have proven to be the primary contributors. There are multiple ways to alleviate heavy periods and effectively managing them. Options include surgical operations, IUD, and the use of...

• HIV: Will My Child Get It If I’m Pregnant?

  The initials 'HIV' stand for Human Immunodeficiency Virus. As the name suggest, it is a viral attack that completely weakens the defense systems of a human being leaving them open to invasion from bacteria and other disease causing micro-organisms.Once infected, the virus finds its way into the...